| Literature DB >> 30213076 |
Najeeb Akhter1, Yaqin Liu2, Bibi Nazia Auckloo3, Yutong Shi4, Kuiwu Wang5, Juanjuan Chen6, Xiaodan Wu7, Bin Wu8.
Abstract
Natural products from marine actinomycetes remain an important resource for drug discovery, many of which are produced by the genus, Streptomyces. However, in standard laboratory conditions, specific gene clusters in microbes have long been considered silent or covert. Thus, various stress techniques activated latent gene clusters leading to isolation of potential metabolites. This study focused on the analysis of two new angucycline antibiotics isolated from the culture filtrate of a marine Streptomyces pratensis strain NA-ZhouS1, named, stremycin A (1) and B (2) which were further determined based on spectroscopic techniques such as high resolution time of flight mass spectrometry (HR-TOF-MS), 1D, and 2D nuclear magnetic resonance (NMR) experiments. In addition, four other known compounds, namely, 2-[2-(3,5-dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide (3), cyclo[l-(4-hydroxyprolinyl)-l-leucine] (4), 2-methyl-3H-quinazoline-4-one (5), and menthane derivative, 3-(hydroxymethyl)-6-isopropyl-10,12-dioxatricyclo[7.2.1.0]dodec-4-en-8-one (6) were obtained and elucidated by means of 1D NMR spectrometry. Herein, we describe the "Metal Stress Technique" applied in the discovery of angucyclines, a distinctive class of antibiotics that are commonly encoded in microbiomes but have never been reported in "Metal Stress" based discovery efforts. Novel antibiotics 1 and 2 exhibited antimicrobial activities against Pseudomonas aeruginosa, methicillin resistant Staphylococcus aureus (MRSA), Klebsiella pneumonia, and Escherichia coli with equal minimum inhibitory concentration (MIC) values of 16 µg/mL, while these antibiotics showed inhibition against Bacillus subtilis at MIC value of approximately 8⁻16 µg/mL, respectively. As a result, the outcome of this investigation revealed that metal stress is an effective technique in unlocking the biosynthetic potential and resulting production of novel antibiotics.Entities:
Keywords: Streptomyces pratensis; antimicrobial activity; marine microorganisms; metal stress technique; polyketide antibiotics
Mesh:
Substances:
Year: 2018 PMID: 30213076 PMCID: PMC6163593 DOI: 10.3390/md16090331
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of stress metabolites 1–6.
Figure 2HPLC analysis metabolic profile of NA-ZhouS1 under nickel ion stress condition.
NMR spectrum data for stremycin A (1), 1H NMR (500 MHz, δ in ppm), 13C NMR (125 MHz, δ in ppm) in MeOD.
| Position | HMBC | COSY | ||
|---|---|---|---|---|
| 1 | 82.1, CH | 4.34, d (4.2) | C-1A, C-2, C-12b, C-4a | H-2 |
| 2 | 120.8, CH | 5.63, s | C-3 | H-1 |
| 3 | 136.6, C | - | - | - |
| 4 | 36.3, CH2 | 1.99, d (17.6); 2.36, d (17.6) | Me-3, C-4a | - |
| 4a | 75.6, C | - | --- | - |
| 5 | 76.2, CH | 5.84, d, (6.8) | C-6, COMe | H-6 |
| 6 | 69.9, CH | 4.92, d, (6.8) | C-5, C-6a, C-12a | H-5 |
| 6a | 145.2, C | - | - | - |
| 7 | 190.5, C | - | - | - |
| 7a | 115.6, C | - | - | - |
| 8 | 158.6, C | - | - | - |
| 9 | 139.3, C | - | - | - |
| 10 | 134.2, CH | 7.87, d (7.9) | C-7a, C-8, C-1B, C11a | H-11 |
| 11 | 120.1, CH | 7.64, d (7.9) | C-7a, C-9, C-12 | H-10 |
| 11a | 132.6, C | - | - | - |
| 12 | 187.2, C | - | - | - |
| 12a | 146.0, C | - | - | - |
| 12b | 78.5, C | - | - | - |
| 3-Me | 23.5, CH3 | 1.68, s | C-3, C-4 | - |
| 5-COMe | 172.3, C | - | - | - |
| 20.9, CH3 | 2.20, s | - | - | |
|
| ||||
| 1A | 100.6, CH | 4.60, d (4.0) | C-1, C-3A, C-5A | H-2A |
| 2A | 30.6, CH2 | 1.31, overlapped; 1.88, m | - | H-1A, H-3A |
| 3A | 78.4, CH | 3.29, m | OMe-3A | H-4A |
| 4A | 66.9, CH | 3.49, m | - | H-5A |
| 5A | 63.4, CH | 4.29, m | - | H-6A |
| 6A | 16.8, CH3 | 1.18, d (6.6) | C-5A | H-5A |
| OMe-3A | 57.5,C | 3.24, s | - | - |
|
| ||||
| 1B | 72.4, CH | 4.89, s | C-10, C-9, C-8, C7a, C-2B, C-3B, C-4B, C-5B | H-2B |
| 2B | 38.6, CH2 | 1.42, d (12.6);2.50, dd (12.1, 4.2) | - | H-1B, H-3B |
| 3B | 82.5, CH | 3.84, m | C-1C | H-4B |
| 4B | 76.8, CH | 3.11, t (8.9) | - | H-5B |
| 5B | 77.7, CH | 3.46, m | C-6B | H-6B |
| 6B | 18.8, CH3 | 1.38, d (6.1) | - | - |
|
| ||||
| 1C | 99.3, CH | 4.78, dd (9.9, 1.8) | C-3B, C-2C | H-2C |
| 2C | 45.6, CH2 | 1.68, overlapped; 1.95, m | C-3C, C-4C | H-1C |
| 3C | 71.5, C | - | - | - |
| 4C | 90.5, CH | 3.19, d (9.6) | C-5C, C-6C, C-1D | H-5C |
| 5C | 71.9, CH | 3.55, m | - | H-6C |
| 6C | 18.5, CH3 | 1.31, d (6.1) | C-5C | H-5C |
| Me-3C | 22.6, CH3 | 1.25, s | C-3C, C-4C | - |
|
| ||||
| 1D | 104.5, CH | 4.62, s | C-4C, C-2D, C-3D | H-2D |
| 2D | 31.4, CH2 | 1.64, m; 1.99, overlapped | - | H-3D |
| 3D | 28.9, CH2 | 1.57, m; 2.14, m | - | H-4D |
| 4D | 73.9, CH | 4.24, dd (10.0, 4.4) | C-6D, CONH2 | H-5D |
| 5D | 75.3, CH | 3.65, m | - | H-6D |
| 6D | 18.2, CH3 | 1.22, d (6.2) | C-5D | - |
| 4D-CONH2 | 159.6, C | - | C-4D | - |
Figure 3The key 1H-1H COSY, HMBC correlations of stremycin A (1).
Figure 4The key plausible MS fragmentation pathway of stremycin A (1) was confirmed by electrospray ionization mass spectroscopy (ESI-MS/MS) analysis in positive mode.
NMR spectrum data for stremycin B (2), 1H NMR (500 MHz, δ in ppm), 13C NMR (125 MHz, δ in ppm) in MeOD.
| Position | HMBC | COSY | ||
|---|---|---|---|---|
| 1 | 81.8, CH | 4.43, d (3.8) | C-1A, C-2, C-3, C-12b, C-4a | H-2 |
| 2 | 123.1, CH | 5.72, d (3.2) | 3-Me, C-4 | H-1 |
| 3 | 138.7, C | - | - | - |
| 4 | 70.5, CH | 4.17, s | 3-Me, C-3, C-4a, C-12b | - |
| 4a | 76.2, C | - | - | - |
| 5 | 75.9, CH | 5.76, d (6.8) | C-6, COMe | H-6 |
| 6 | 69.8, CH | 4.91, m (6.8) | C-5, C-6a, C-12a | H-5 |
| 6a | 144.5, C | - | - | - |
| 7 | 190.8, C | - | - | - |
| 7a | 115.6, C | - | - | - |
| 8 | 158.7, C | - | - | - |
| 9 | 139.4, C | - | - | - |
| 10 | 134.2, CH | 7.85 d (7.7) | C-8, C-1B, C11a | H-11 |
| 11 | 120.0, CH | 7.61, d (7.7) | C-7a, C-9, C-12 | H-10 |
| 11a | 132.5, C | - | - | - |
| 12 | 187.3, C | - | - | - |
| 12a | 146.7, C | - | - | - |
| 12b | 79.7, C | - | - | - |
| 3-Me | 21.9, CH3 | 1.95, s | C-3, C-4 | - |
| 5-COMe | 173.0, C | - | - | - |
| 20.6, CH3 | 2.02, s | - | - | |
|
| ||||
| 1A | 100.9, CH | 4.57, d (4.4) | C-1, C-3A, C-5A | H-2A |
| 2A | 30.3, CH2 | 1.32, overlapped; 1.85, m | C-1A | H-1A, H-3A |
| 3A | 78.4, CH | 3.27, m | C-4A | H-4A |
| 4A | 67.5, CH | 3.47, m | - | H-5A |
| 5A | 63.7, CH | 4.10, d (6.5) | - | H-6A |
| 6A | 16.8, CH3 | 1.17, d (6.6) | C-5A | H-5A |
| OMe-3A | 57.7, C | 3.30, s | - | - |
|
| ||||
| 1B | 72.4, CH | 4.87, m (overlapped) | C-9, C-10 | H-2B |
| 2B | 38.6, CH2 | 1.42, m; 2.49, dd (12.3, 4.6) | C-3B, C-4B | H-1B, H-3B |
| 3B | 82.3, CH | 3.84, m | C-4B, C-1C | H-4B |
| 4B | 76.9, CH | 3.11, dd (11.1, 6.7) | C-3B, C-5B, C-6B | H-5B |
| 5B | 77.7, CH | 3.44, dd (6.9, 3.5) | C-6B | H-6B |
| 6B | 18.8, CH3 | 1.37, d (6.1) | C-5B | - |
|
| ||||
| 1C | 99.3, CH | 4.77, d (9.9) | C-3B, C-2C | H-2C |
| 2C | 45.6, CH2 | 1.95, overlapped; 1.67, m | C-3C, C-4C | H-1C |
| 3C | 71.5, C | - | - | - |
| 4C | 90.5, CH | 3.18, d (9.6) | Me-3C, C-5C, C-6C, C-1D | H-5C |
| 5C | 72.0, CH | 4.81, d (6.5) | --- | H-6C |
| 6C | 18.5, CH3 | 1.30, d (6.1) | C-5C | H-5C |
| Me-3C | 22.6, CH3 | 1.25, s | C-3C, C-4C | - |
|
| ||||
| 1D | 104.5, CH | 4.61, d (9.2) | C-4C, C-2D, C-3D | H-2D |
| 2D | 31.4, CH2 | 1.99, m; 1.63, m | - | H-3D |
| 3D | 28.9, CH2 | 2.14, m; 1.59, m | - | H-4D |
| 4D | 73.9, CH | 4.24, dd (9.7, 5.5) | C-6D, CONH2 | H-5D |
| 5D | 75.3, CH | 3.62, m | - | H-6D |
| 6D | 18.2, CH3 | 1.22, d (6.1) | C-5D | - |
| 4D-CONH2 | 159.6, C | - | C-4D | - |